Advances in allergic skin disease: Omalizumab is a promising therapy for urticaria and angioedema

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 1, 2009, Pages 273-274

  Spector, Sheldon L ^a   Tan, Ricardo A ^a  

^a California Allergy and Asthma Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; OMALIZUMAB;

ANGIONEUROTIC EDEMA; ANTIBODY BLOOD LEVEL; CASE REPORT; CHRONIC URTICARIA; CLINICAL TRIAL; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; IDIOPATHIC DISEASE; LETTER; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TREATMENT RESPONSE;

ANAPHYLAXIS; ANIMALS; CLINICAL TRIALS AS TOPIC; DRUG HYPERSENSITIVITY; FOOD HYPERSENSITIVITY; HUMANS; INSECT BITES AND STINGS; SKIN DISEASES;

EID: 58149140086     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.07.033     Document Type: Letter

References (5)

1. Sicherer S.H., and Leung D.Y.M. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2007. J Allergy Clin Immunology 121 (2008) 1351-1358
2. Sands M.F., Blume J.W., and Schwartz S.A. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol 120 (2007) 979-981
3. Spector S.L., and Tan R.A. Effect of omalizumab in patients with chronic urticaria. Ann Allergy Asthma Immunol 99 (2007) 190-193
4. Boyce J.A. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 117 (2006) 1415-1418
5. Metz M., Bergmann P., Zuberbier T., and Maurer M. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 63 (2008) 247-249